Prevalence and determinants of left ventricular hypertrophy in acromegaly: Impact of different methods of indexing left ventricular mass

Clinical Endocrinology

Volumn 60, Issue 3, 2004, Pages 343-349

  Vitale, Giovanni ^a   Galderisi, Maurizio ^a   Pivonello, Rosario ^a   Spinelli, Letizia ^a   Ciccarelli, Antonio ^a   De Divitiis, Oreste ^a   Lombardi, Gaetano ^a   Colao, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; ADULT; ARTICLE; BODY HEIGHT; BODY SIZE; BODY SURFACE; CALCULATION; CONTROLLED STUDY; EVALUATION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL;

ACROMEGALY; ACUTE DISEASE; ADULT; BODY HEIGHT; BODY MASS INDEX; BODY SURFACE AREA; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; PREVALENCE;

EID: 1542269637     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.01985.x     Document Type: Article

References (39)

1. American Diabetes Association (Committee Report). (2003) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 26, S5-S20.
2. Bengtsson, B.A., Brummer, R.J. & Bosaeus, I. (1990) Growth hormone and body composition. Hormone Research, 33, 19-24.
3. Brummer, R.J.M., Lonn, L., Bengtsson, B.A., Kuist, H., Bosaeus, I. & Sjostrom, L. (1996) Comparison of different body composition models in acromegaly. Growth Regulation, 6, 191-200.
4. Clayton, R.N. (2003) Cardiovascular function in acromegaly. Endocrine Reviews, 24, 272-277.
5. Colao, A. (2001) Are patients with acromegaly at high risk for dysrhythmias? Clinical Endocrinology, 55, 305-306.
6. Colao, A. & Lombardi, G. (1998) Growth hormone and prolactin excess. Lancet, 352, 1455-1461.
7. Colao, A., Merola, B., Ferone, D. & Lombardi, G. (1997) Acromegaly. Journal of Clinical Endocrinology and Metabolism, 82, 2777-2781.
8. Colao, A., Baldelli, R., Marzullo, P., Ferretti, E., Ferone, D., Gargiulo, P., Petretta, M., Tamburrano, G., Lombardi, G. & Liuzzi, A. (2000) Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. Journal of Clinical Endocrinology and Metabolism, 85, 193-199.
9. Colao, A., Marzullo, P., Di Somma, C. & Lombardi, G. (2001) Growth hormone and the heart. Clinical Endocrinology, 54, 137-154.
10. Colao, A., Spinelli, L., Cuocolo, A., Spiezia, S., Pivonello, R., Di Somma, C., Bonaduce, D., Salvatore, M. & Lombardi, G. (2002) Cardiovascular consequences of early-onset growth hormone excess. Journal of Clinical Endocrinology and Metabolism, 87, 3097-3104.
11. Colao, A., Marzullo, P., Cuocolo, A., Spinelli, L., Pivonello, R., Bonaduce, D., Salvatore, M. & Lombardi, G. (2003) Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with depot long-acting somatostatin analogue octreotide. Clinical Endocrinology, 58, 169-176.
12. Daniels, S.R., Kimball, T.R., Morrison, J.A., Khoury, P. & Meyer, R.A. (1995) Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Journal of American College of Cardiology, 76, 699-701.
13. DECODE Study Group on behalf of the European Diabetes Epidemiology Group. (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet, 354, 617-621.
14. Devereux, R.B. (1987) Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization and comparison to other methods. Hypertension, 9, 19-26.
15. Devereux, R.B. & Reicheck, N. (1977) Echocardiographic determination of left ventricular mass: anatomic validation of the method. Circulation, 55, 613-618.
16. Galdersi, M., Lauer, M.S. & Levy, D. (1992) Echocardiographic determinants of clinical outcome in subjects with coronary artery disease (the Framingham Heart Study). American Journal of Cardiology, 70, 971-976.
17. Giustina, A., Barkan, A., Casanueva, F.F., Cavagnini, F., Frohman, L.H.K., Veldhuis, J., Wass, J., Von Werder, K. & Melmed, S. (2000) Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 85, 526-529.
18. Gutgesell, H.P. & Rembold, C.M. (1990) Growth of the human heart relative to body surface area. American Journal of Cardiology, 65, 662-668.
19. Hejtmancik, M.R., Bradfield, J.Y. & Herrmann, G.R. (1951) Acromegaly and the heart. a clinical and pathologic study. Annals of International Medicine, 34, 1445-1456.
20. Herrmann, B.L., Bruch, C., Saller, B., Ferdin, S., Dagres, N., Ose, C., Erbel, R. & Mann, K. (2001) Occurrence of ventricular late potentials in patients with active acromegaly. Clinical Endocrinology, 55, 201-207.
21. Holdaway, I.M. & Rajasoorya, C. (1999) Epidemiology of acromegaly. Pituitary, 2, 29-41.
22. WHO (1996) Hypertension Control. Report of a WHO expert committee. World Health Organization Technical Report Series, 862, 1-83.
23. Isgaard, J., Tivesten, A., Friberg, P. & Bengtsson, B.A. (1999) The role of the GH/IGF-I axis for cardiac function and structure. Hormone and Metabolic Research, 31, 50-54.
24. Kahaly, G., Olshausen, K.V., Mohr-Kahaly, S., Erbel, R., Boor, S., Beyer, J. & Meyer, J. (1992) Arrhythmia profile in acromegaly. European Heart Journal, 13, 51-56.
25. Lauer, M.S., Anderson, K.M., Larson, M.G. & Levy, D. (1994) A new method for indexing left ventricular mass for differences in body size. American Journal of Cardiology, 74, 487-491.
26. Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B. & Castelli, W.P. (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New England Journal of Medicine, 322, 1561-1566.
27. Lie, J.T. & Grossman, S.J. (1980) Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. American Heart Journal, 100, 41-52.
28. Lombardi, G., Colao, A., Marzullo, P., Biondi, B., Palmieri, E. & Fazio, S. and the Multicenter Italian Study Group (2002) on Lanreotide. Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced growth hormone and insulin-like growth factor-I decrease in acromegaly: a single-blind prospective multicenter study. Journal of Endocrinological Investigation, 25, 971-976.
29. Lopez-Velasco, R., Escobar-Morreale, H.F., Vega, B., Villa, E., Sancho, J.M., Moya-Mur, J.L. & Garcia-Robles, R. (1997) Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension. Journal of Clinical Endocrinology and Metabolism, 82, 1047-1053.
30. Nabarro, J.D.N. (1987) Acromegaly. Clinical Endocrinology, 26, 481-512.
31. National Institute of Health Consensus Development Panel on the Health Implication of Obesity (1985) Health implication of obesity. Annals of International Medicine, 103, 1073-1077.
32. Palmieri, V., De Simone, G., Arnett, D.K., Bella, J.N., Kitzman, D.W., Oberman, A., Hopkins, P.N., Province, M.A. & Devereux, R.B. (2001) Relations of various degrees of body mass index in patients with systemic hypertension to left ventricular mass cardiac output and peripheral resistance (The Hypertension Genetic Epidemiology Network Study). American Journal of Cardiology, 88, 1163-1168.
33. Rajasoorya, C., Holdaway, I.M., Wrightson, P., Scott, D.G. & Ibbertson, H.K. (1994) Determinants of clinical outcome and survival in acromegaly. Clinical Endocrinology, 41, 95-102.
34. Sahn, D.J., DeMaria, A., Kisslo, J. & Weyman, A. (1978) for the Committee of M-Mode standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-Mode echocardiography: results of a survey of echocardiographic measurements. Circulation, 58, 1072-1083.
35. de Simone, G., Daniels, S.R., Devereux, R.B., Meyer, R.A., Roman, M.J., de Divitiis, O. & Laragh, J. (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. Journal of the American College of Cardiology, 20, 1251-1260.
36. de Simone, G., Devereux, R.B., Roman, M.J., Alderman, M.H. & Laragh, J.H. (1994) Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension, 23, 600-606.
37. Tominaga, A., Arita, K., Kurisu, K., Uozumi, T., Migita, K., Eguchi, K., Iida, K., Kawamoto, K. & Mizoue, T. (1998) Effects of successful adenomectomy on body composition in acromegaly. Endocrine Journal, 45, 335-342.
38. Vitale, G., Pivonello, R., Galderisi, M., D'Errico, A., Spinelli, L., Lupoli, G., Lombardi, G. & Colao, A. (2001) Cardiovascular complications in acromegaly: methods of assessment. Pituitary, 4, 251-257.
39. Wright, A.D., Hill, D.M., Lowy, C. & Fraser, T.R. (1970) Mortality in acromegaly. Quarterly Journal of Medicine, 39, 1-16.